β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer’s disease

Synaptic degeneration is an early event closely associated with the course of Alzheimer’s disease (AD). The identification of synaptic blood biomarkers is, therefore, of great interest and clinical relevance. The levels of most synaptic proteins are increased in the cerebrospinal fluid (CSF) of pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohaupt, Pablo, Pons, Marie-Laure, Vialaret, Jérôme, Delaby, Constance, Hirtz, Christophe, Lehmann, Sylvain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710176/
https://www.ncbi.nlm.nih.gov/pubmed/36451155
http://dx.doi.org/10.1186/s13195-022-01125-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710176/
https://www.ncbi.nlm.nih.gov/pubmed/36451155
http://dx.doi.org/10.1186/s13195-022-01125-1

Ejemplares similares